{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:02:42Z","timestamp":1789243362500,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.mcna.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T11:56:33Z","timestamp":1661514993000},"page":"899-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diet for Functional Gastrointestinal Disorders\/Disorders of Gut\u2013Brain Interaction"],"prefix":"10.1016","volume":"106","author":[{"given":"Sydney","family":"Pomenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Jodorkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.mcna.2022.03.005_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5056\/jnm.2013.19.3.332","article-title":"Specific movement of esophagus during transient lower esophageal sphincter relaxation in gastroesophageal reflux disease","volume":"19","author":"Kim","year":"2013","journal-title":"J\u00a0Neurogastroenterol Motil"},{"issue":"Suppl 12","key":"10.1016\/j.mcna.2022.03.005_bib3","doi-asserted-by":"crossref","first-page":"S1594","DOI":"10.21037\/jtd.2019.06.42","article-title":"The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn","volume":"11","author":"Newberry","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/gut.2004.040337","article-title":"Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers","volume":"54","author":"El-Serag","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2036.2006.03170.x","article-title":"Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease","volume":"25","author":"Shapiro","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.mcna.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.mcna.2022.03.005_bib7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ajg.2013.196","article-title":"ACG clinical guideline: diagnosis and management of achalasia","volume":"108","author":"Vaezi","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10620-020-06414-z","article-title":"Study Group for the Evaluation of GERD Triggering Foods. Elimination of dietary triggers is successful in treating symptoms of gastroesophageal reflux disease","volume":"66","author":"Tosetti","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ptr.3229","article-title":"Anti-heartburn effects of a fenugreek fiber product","volume":"25","author":"DiSilvestro","year":"2011","journal-title":"Phytother Res"},{"issue":"21","key":"10.1016\/j.mcna.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3748\/wjg.v24.i21.2291","article-title":"Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease","volume":"24","author":"Morozov","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.mcna.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11894-019-0707-4","article-title":"Popular remedies for esophageal symptoms: a critical appraisal","volume":"21","author":"Ahuja","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib12","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.mcna.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mcna.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jhn.12506","article-title":"Food and functional dyspepsia: a systematic review","volume":"31","author":"Duncanson","year":"2018","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.mcna.2022.03.005_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15410","article-title":"Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial","author":"Goyal","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ajg.2013.96","article-title":"Short-chain carbohydrates and functional gastrointestinal disorders","volume":"108","author":"Shepherd","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.mcna.2022.03.005_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu12071947","article-title":"Wheat sensitivity and functional dyspepsia: a pilot, double-blind, randomized, placebo-controlled dietary crossover trial with novel challenge protocol","volume":"12","author":"Potter","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.mcna.2022.03.005_bib19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1365-2036.2000.00873.x","article-title":"Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia","volume":"14","author":"May","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mcna.2022.03.005_bib20","doi-asserted-by":"crossref","first-page":"e00021","DOI":"10.14309\/ctg.0000000000000021","article-title":"A\u00a0novel, duodenal-release formulation of a combination of caraway oil and l-menthol for the treatment of functional dyspepsia: a randomized controlled trial","volume":"10","author":"Chey","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.mcna.2022.03.005_bib21","article-title":"Bowel Disorders","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.mcna.2022.03.005_bib22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.mcna.2022.03.005_bib23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2036.2005.02463.x","article-title":"Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact","volume":"21","author":"Hungin","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2022.03.005_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-med-050218-013625","article-title":"Low-FODMAP diet for irritable bowel syndrome: what we know and what we have yet to learn","volume":"71","author":"Liu","year":"2020","journal-title":"Annu Rev Med"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","article-title":"Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial","volume":"149","author":"B\u00f6hn","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2022.03.005_bib26","doi-asserted-by":"crossref","first-page":"h701","DOI":"10.1136\/bmj.h701","article-title":"Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance","volume":"350","author":"Hookway","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mcna.2022.03.005_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1440-1746.2009.06149.x","article-title":"Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach","volume":"25","author":"Gibson","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jhn.12385","article-title":"British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)","volume":"29","author":"McKenzie","year":"2016","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ajg.2013.63","article-title":"Fiber and functional gastrointestinal disorders","volume":"108","author":"Eswaran","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2022.03.005_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jgh.13688","article-title":"Nutritional, microbiological and psychosocial implications of the low FODMAP diet","volume":"32","author":"Staudacher","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.mcna.2022.03.005_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/jgh.14650","article-title":"Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome","volume":"34","author":"Halmos","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.mcna.2022.03.005_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","article-title":"A\u00a0systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome","volume":"113","author":"Dionne","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2013.01.049","article-title":"A\u00a0controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function","volume":"144","author":"Vazquez-Roque","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010148","article-title":"Low FODMAP diet: evidence, doubts, and hopes","volume":"12","author":"Bellini","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.mcna.2022.03.005_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jhn.12018","article-title":"Nutritional inadequacies of the gluten-free diet in both recently-diagnosed and long-term patients with coeliac disease","volume":"26","author":"Shepherd","year":"2013","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"3","key":"10.1016\/j.mcna.2022.03.005_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","article-title":"Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions","volume":"7","author":"Ohman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2022.03.005_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nutres.2021.02.003","article-title":"Lactose intolerance: An update on its pathogenesis, diagnosis, and treatment","volume":"89","author":"Catanzaro","year":"2021","journal-title":"Nutr Res"},{"issue":"8","key":"10.1016\/j.mcna.2022.03.005_bib38","doi-asserted-by":"crossref","first-page":"e0182942","DOI":"10.1371\/journal.pone.0182942","article-title":"Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies","volume":"12","author":"Varj\u00fa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2022.03.005_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clnesp.2020.09.020","article-title":"Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study","volume":"40","author":"Krieger-Gr\u00fcbel","year":"2020","journal-title":"Clin Nutr ESPEN"},{"issue":"10170","key":"10.1016\/j.mcna.2022.03.005_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","article-title":"Carbohydrate quality and human health: a series of systematic reviews and meta-analyses","volume":"393","author":"Reynolds","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib41","first-page":"1207","article-title":"Meta-analyses of colorectal cancer risk factors","volume":"24","author":"Johnson","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"9368","key":"10.1016\/j.mcna.2022.03.005_bib42","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(03)13173-X","article-title":"Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme","volume":"361","author":"Peters","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mcna.2022.03.005_bib45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1745-7599.2012.00758.x","article-title":"Viscous versus nonviscous soluble fiber supplements: mechanisms and evidence for fiber-specific health benefits","volume":"24","author":"Chutkan","year":"2012","journal-title":"J\u00a0Am Acad Nurse Pract"},{"issue":"6160","key":"10.1016\/j.mcna.2022.03.005_bib46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.1.6160.376","article-title":"Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk","volume":"1","author":"Ritchie","year":"1979","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-95-1-53","article-title":"Psyllium therapy in the irritable bowel syndrome. A double-blind trial","volume":"95","author":"Longstreth","year":"1981","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib48","first-page":"253","article-title":"Double blind trial of ispaghula\/poloxamer in the Irritable Bowel Syndrome","volume":"76","author":"Arthurs","year":"1983","journal-title":"Ir Med J"},{"issue":"12","key":"10.1016\/j.mcna.2022.03.005_bib49","first-page":"1041","article-title":"Different therapeutic regimens in irritable bowel syndrome","volume":"32","author":"Nigam","year":"1984","journal-title":"J\u00a0Assoc Physicians India"},{"issue":"11","key":"10.1016\/j.mcna.2022.03.005_bib50","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gut.28.11.1510","article-title":"Double blind study of ispaghula in irritable bowel syndrome","volume":"28","author":"Prior","year":"1987","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1746.1990.tb01432.x","article-title":"Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction","volume":"5","author":"Jalihal","year":"1990","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2022.03.005_bib52","doi-asserted-by":"crossref","first-page":"b3154","DOI":"10.1136\/bmj.b3154","article-title":"Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial","volume":"339","author":"Bijkerk","year":"2009","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.mcna.2022.03.005_bib53","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ajg.2014.195","article-title":"The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis","volume":"109","author":"Moayyedi","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"7954","key":"10.1016\/j.mcna.2022.03.005_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(76)91402-1","article-title":"A\u00a0double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome","volume":"1","author":"Soltoft","year":"1976","journal-title":"Lancet"},{"issue":"8035","key":"10.1016\/j.mcna.2022.03.005_bib55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(77)90605-5","article-title":"Wheat fibre and irritable bowel syndrome. A controlled trial","volume":"2","author":"Manning","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mcna.2022.03.005_bib56","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000199329","article-title":"Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome","volume":"34","author":"Kruis","year":"1986","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.mcna.2022.03.005_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/gut.28.2.221","article-title":"Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study","volume":"28","author":"Lucey","year":"1987","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/146642400512500112","article-title":"Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome","volume":"125","author":"Rees","year":"2005","journal-title":"J\u00a0R Soc Promot Health"},{"issue":"12","key":"10.1016\/j.mcna.2022.03.005_bib59","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/apt.13167","article-title":"Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome","volume":"41","author":"Rao","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.mcna.2022.03.005_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib62","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","article-title":"Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome","volume":"29","author":"Silk","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"S1","key":"10.1016\/j.mcna.2022.03.005_bib63","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.27.1_supplement.lb426","article-title":"Efficacy of inulin enriched yogurt on bowel habits in patients with irritable bowel syndrome with constipation: a pilot study","volume":"27","author":"Isakov","year":"2013","journal-title":"FASEB J"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2022.03.005_bib64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.13700","article-title":"Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders","volume":"32","author":"Wilson","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.mcna.2022.03.005_bib65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bpg.2003.10.006","article-title":"Microbial-gut interactions in health and disease","volume":"18","author":"Isolauri","year":"2004","journal-title":"Probiotics Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.mcna.2022.03.005_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nut.2017.06.024","article-title":"Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration","volume":"45","author":"Parker","year":"2018","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.mcna.2022.03.005_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ajg.2009.25","article-title":"The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review","volume":"104","author":"Brenner","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.mcna.2022.03.005_bib68","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12906-018-2409-0","article-title":"The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data","volume":"19","author":"Alammar","year":"2019","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib70","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10620-009-0854-9","article-title":"The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome","volume":"55","author":"Merat","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2022.03.005_bib71","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib72","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.dld.2007.02.006","article-title":"Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial","volume":"39","author":"Cappello","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib73","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF02936952","article-title":"Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial","volume":"32","author":"Liu","year":"1997","journal-title":"J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.mcna.2022.03.005_bib74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-015-3858-7","article-title":"A\u00a0novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms","volume":"61","author":"Cash","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.mcna.2022.03.005_bib75","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2011.164","article-title":"Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis","volume":"106","author":"Suares","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2022.03.005_bib76","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2022.03.005_bib77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1742-1241.1986.tb07949.x","article-title":"A\u00a0general practice study of the efficacy of Regulan in functional constipation","volume":"40","author":"Fenn","year":"1986","journal-title":"Br J Clin Pract"},{"issue":"2","key":"10.1016\/j.mcna.2022.03.005_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000200705","article-title":"A\u00a0double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation","volume":"49","author":"Odes","year":"1991","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib79","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2036.1995.tb00433.x","article-title":"Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation","volume":"9","author":"Ashraf","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2022.03.005_bib80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JXX.0000000000000346","article-title":"Laxative effects of wheat bran and psyllium: Resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation","volume":"32","author":"McRorie","year":"2020","journal-title":"J\u00a0Am Assoc Nurse Pract"},{"key":"10.1016\/j.mcna.2022.03.005_bib81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1475-2891-12-78","article-title":"Effects of Kivia powder on gut health in patients with occasional constipation: a randomized, double-blind, placebo-controlled study","volume":"12","author":"Udani","year":"2013","journal-title":"Nutr J"},{"issue":"9","key":"10.1016\/j.mcna.2022.03.005_bib82","doi-asserted-by":"crossref","first-page":"e13874","DOI":"10.1111\/nmo.13874","article-title":"The effect of green kiwifruit on gas transit and tolerance in healthy humans","volume":"32","author":"Caballero","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"10.1016\/j.mcna.2022.03.005_bib83","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-2036.2011.04594.x","article-title":"Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation","volume":"33","author":"Attaluri","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.mcna.2022.03.005_bib84","doi-asserted-by":"crossref","first-page":"e1701034","DOI":"10.1002\/mnfr.201701034","article-title":"Polyphenol-rich Mango (Mangifera indica L.) Ameliorate Functional Constipation Symptoms in Humans beyond Equivalent Amount of Fiber","volume":"62","author":"Venancio","year":"2018","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"10.1016\/j.mcna.2022.03.005_bib85","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.14309\/ajg.0000000000001149","article-title":"Exploratory comparative effectiveness trial of green kiwifruit, psyllium, or prunes in US patients with chronic constipation","volume":"116","author":"Chey","year":"2021","journal-title":"Am J Gastroenterol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:47:37Z","timestamp":1758419257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712522000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0025712522000372"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2022.03.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet for Functional Gastrointestinal Disorders\/Disorders of Gut\u2013Brain Interaction","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}